Section one: Contracting authority
one.1) Name and addresses
Greater Manchester ICB
Tootal Buildings, 56 Oxford Street
Manchester
M16EU
Contact
Sarah Golby
Country
United Kingdom
Region code
UKD33 - Manchester
Justification for not providing organisation identifier
Not on any register
Internet address(es)
Main address
https://gmintegratedcare.org.uk/
one.3) Communication
The procurement documents are available for unrestricted and full direct access, free of charge, at
https://www.sap.com/products/spend-management/ariba-login.html
Additional information can be obtained from the above-mentioned address
Tenders or requests to participate must be submitted electronically via
https://www.sap.com/products/spend-management/ariba-login.html
one.4) Type of the contracting authority
Body governed by public law
one.5) Main activity
Health
Section two: Object
two.1) Scope of the procurement
two.1.1) Title
Procurement for Intravenous Therapy and Bisphosphonates Service on behalf of Greater Manchester Integrated Care Board
two.1.2) Main CPV code
- 85100000 - Health services
two.1.3) Type of contract
Services
two.1.4) Short description
The aim of the IV therapy and Bisphosphonates service is to enable Stockport patients aged 18 years and over who are medically stable to safely receive intravenous therapy in a community health care setting or the patient's own home for selected frail and housebound patients, thereby reducing avoidable hospital admissions and facilitating early hospital discharge.
The community IV service is predominantly to avoid hospital admissions (step-up) for patients requiring IV antibiotic once daily treatment (OD) or twice daily (BD) for a short duration (average 3 days, maximum 15 days). The service will also accept a number of referrals for step down patients from hospital. Where clinically appropriate the service will empower patients to self-administer.
The key objectives of this service are:
1. To provide high quality care closer to home to meet patient's needs.
2. To avoid hospital admissions.
3. To support early hospital discharge.
4. To provide timely access to assessment, treatment and care which is safe and effective to manage patients requiring IV therapy in the community.
5. Following clinical assessment and where capacity permits to offer IV hydration therapy for the treatment of dehydration. A management plan will be in place to help avoid hospital admission.
6. To support the Stockport sexual health team in Out of Hours and bank holidays with patient who require daily IM injections of Procaine.
For full details of the Service and any additional information regarding this Procurement please see link to the Specification and Invitation to Tender documentation that can be accessed via SAP Ariba. Invitation to Tender documentation can be accessed via SAP Ariba reference https://discovery.ariba.com/rfx/23131647
Please return your completed ITT Tender pack through the SAP Ariba Portal by 13 June at 12 noon.
two.1.5) Estimated total value
Value excluding VAT: £3,087,540
two.1.6) Information about lots
This contract is divided into lots: No
two.2) Description
two.2.3) Place of performance
NUTS codes
- UKD - North West (England)
Main site or place of performance
Greater Manchester - Stockport
two.2.4) Description of the procurement
This is a competitive ITT conducted in accordance with the Competitive Process under the Health Care Services (Provider Selection Regime) Regulations 2023 (the "Regulations")
The procurement of the Services is being run as a bespoke, single-stage application process.
The community Intravenous (IV) Therapy and Bisphosphonates service will enable medically stable patients to receive short term intravenous or subcutaneous therapy in a community health care setting such as a clinic, or in their own home for eligible frail and housebound patients.
The Contract to be awarded as a result of this Procurement will have an initial term of three -years commencing from 01 April 2026. The Authority will also have the option extend the initial term of the Contract to a maximum term of five years to 31 March 2031 (3years + 2years).
two.2.5) Award criteria
Price is not the only award criterion and all criteria are stated only in the procurement documents
two.2.6) Estimated value
Value excluding VAT: £3,087,540
two.2.7) Duration of the contract, framework agreement or dynamic purchasing system
Duration in months
60
This contract is subject to renewal
No
two.2.10) Information about variants
Variants will be accepted: No
two.2.11) Information about options
Options: No
Section four. Procedure
four.1) Description
four.1.1) Type of procedure
Open procedure
four.1.8) Information about the Government Procurement Agreement (GPA)
The procurement is covered by the Government Procurement Agreement: No
four.2) Administrative information
four.2.2) Time limit for receipt of tenders or requests to participate
Date
13 June 2025
Local time
12:00pm
four.2.4) Languages in which tenders or requests to participate may be submitted
English
four.2.7) Conditions for opening of tenders
Date
13 June 2025
Local time
4:00pm
Section six. Complementary information
six.1) Information about recurrence
This is a recurrent procurement: No
six.4) Procedures for review
six.4.1) Review body
NHS Greater Manchester Integrated Care Board
Manchester
Country
United Kingdom